The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Vinorelbine-induced phlebitis is common in patients receiving adjuvant chemotherapy for non-small cell lung cancer (NSCLC).
 
Elaine Shum
No Relationships to Disclose
 
Balazs Halmos
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Celgene; Genentech/Roche
Research Funding - AstraZeneca; Boehringer Ingelheim; HealthCare Ventures; Merck; Mirati Therapeutics; Roche/Genentech
 
Haiying Cheng
No Relationships to Disclose
 
Roman Perez-Soler
Consulting or Advisory Role - AZD; Boehringer Ingelheim; Clovis Oncology; Genentech/Roche; Merck Serono; Vertex
 
Rasim A. Gucalp
Consulting or Advisory Role - Amgen
Travel, Accommodations, Expenses - Amgen
 
Stuart H. Packer
No Relationships to Disclose
 
Steven M. Keller
No Relationships to Disclose
 
Amit Bhargava
No Relationships to Disclose
 
Yoko Eng
No Relationships to Disclose
 
Elizabeth Ravera
No Relationships to Disclose
 
Cheryl Baker
No Relationships to Disclose
 
Shankar Viswanathan
No Relationships to Disclose
 
Cecilia Na
No Relationships to Disclose
 
Srikanth Gajavelli
No Relationships to Disclose
 
Royston Browne
No Relationships to Disclose
 
Missak Haigentz
Stock and Other Ownership Interests - Roche